Institutional Biosafety Committee (IBC)
About the IBC
The NDSU Institutional Biosafety Committee (IBC) assures the safe use of recombinant or synthetic nycleic acids, infectious agents, human blood, bodily fluids and tissues and maintains compliance with federal regulations and University policies.
Pathogens and recombinant or synthetic nycleic acids have the potential of endangering the health of people and animals in laboratories and in society. The federal government requires that all institutions that receive federal funding appoint a committee to review the proposed use of these agents by researchers associated with their institution.
The National Institutes of Health (NIH) has established guidelines for institutions involved with recombinant or synthetic nycleic acids research, to assist in the protection of health and environment. It is the responsibility of each institution to ensure that all such activities conducted at, or sponsored by, the institution are in compliance with the National Institutes of Health guidelines.
North Dakota State University has established biosafety policy and procedure in accordance with the NIH Guidelines to ensure safe use of recombinant or synthetic nycleic acids by NDSU investigators. In addition, the NDSU Institutional Biosafety Committee, in collaboration with the Office of Safety and Environmental Health, approves and oversees all activities using infectious agents, human blood, bodily fluids and tissues.
For more information, contact:
- IBC Office, NDSU Office of Research and Creative Activity - 701.231.8908 or email@example.com (IBC review)
- Biological Safety Officer, NDSU Office of Safety and Environmental Health - 701.231.9543